James Marken - ANI Pharmaceuticals Insider

ANI Pharmaceuticals Inc -- USA Stock  

USD 69.74  0.2  0.29%

VP of Operations

Mr. James G. Marken is Vice President Operations of the Company. He has served as the Companys Vice President, Operations, since June 2013 and was promoted to Senior Vice President, Operations and Product Development in May 2016. Mr. Marken joined ANIP in March 2007 as General Manager of the Minnesota facilities. As Vice President, Operations and Product Development, Mr. Marken was principally responsible for the following areas manufacturing, packaging, engineeringmaintenance, purchasing, and warehousing. Mr. Marken brings over 20 years of pharmaceutical industry experience to the Company. Prior to joining ANIP in March 2007, he worked for Solvay Pharmaceuticals as plant manager and in various departments including quality control, validation and manufacturing
Age: 53  VP Since 2013      
218-634-3500  www.biosantepharma.com
Marken holds a B.S. degree in Chemistry from Bemidji State University.

Management Efficiency

The company has return on total asset (ROA) of 7.09 % which means that it generated profit of $7.09 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 4.25 % meaning that it created $4.25 on every $100 dollars invested by stockholders.
The company currently holds 151.28 M in liabilities with Debt to Equity (D/E) ratio of 82.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ANI Pharmaceuticals Inc has Current Ratio of 3.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 2 records

VP Since

Marc KirchmeierVBI Vaccines Inc
Naamit SherVascular Biogenics Ltd

Entity Summary

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. ANI Pharmaceuticals Inc (ANIP) is traded on NASDAQ General Markets in USA. It is located in MINNESOTA, U.S.A and employs 108 people. ANI Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio Reporting Now

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
Hide  View All  NextLaunch Portfolio Reporting
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ANI Pharmaceuticals Inc to your portfolio

Top Management

ANI Pharmaceuticals Inc Leadership Team
Robert Brown, Chairman, MBA
Charlotte Arnold, President, MBA
Mark Ginski, President, Ph.D
Robert Schrepfer, VP, MBA
Daniel Raynor, Director
Stephen Carey, President
David Sullivan, VP, Ph.D
Karen Quinn, President
James Marken, VP
Peter Lankau, Director
Fred Holubow, Director
Tracy Marshbanks, Director
Arthur Przybyl, CEO
Thomas Penn, Director

Stock Performance

ANI Pharmaceuticals Performance Indicators